3H’s DCT approach for Convenience, Diversity, and Data-Driven Insights.
The Way Forward for Decentralise Clinical Trials in Japan: As Decentralized clinical trials, brings participants the opportunity of participating in...
Uchiken: 3H’ Clinical Trial Specialized Nursing Station
Uchiken; 3H`s owned Home Nursing station achieves accreditation as Certified Home Nursing Service Provider, Enabling Enhanced Access to Clinical Trials...
3H Medi Solution and Genequest are collaborating to establish a patient registry for inflammatory bowel disease (IBD)
Initiating the provision of analysis information on differences in drug effects for each genetic polymorphism for contributing to the advancement...
The Successful attaining the Recruitment Targets in Japan and 3H’s optimizing holistic approach for Challenging Clinical Trials.
When conducting clinical trials, it is important to have a well-constructed recruitment pathway. Clinical trials which fail to meet the...
3H’s evolved Patient Recruitment approach for Decentralized Clinical Trials
Recruitment remains a key challenge in clinical trial conduct. With the clinical trial protocols becoming more complex with stringent inclusion...
A paradigm shift of Digital Health Technologies and 3H’s roles for transforming the Clinical Trial conduct in Japan.
The world is transitioning into the information age in healthcare and modern digital health technologies have a lot to offer...
Initiation of Providing “Fukusapo”, an Adverse Drug Reaction Management Supporting Tool for Patients Receiving Treatment with Immune Checkpoint Inhibitors
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; Representative Director, President, Gyo Sagara; “ONO”) and 3H Clinical Trial Inc. (Tokyo, Japan; Representative...
The Changing Landscape of the Asian Clinical Research Industry: Focusing the DCT in Japan.
Clinical trial conduct is a substantial investment requiring the right mix of resources and time. With the pharmaceutical industry facing...